Quick Takeaways
- Dellora Investments LP filed SCHEDULE 13G/A for TENAX THERAPEUTICS, INC. Common Stock, $0.0001 par value per share (TENX).
- Disclosed ownership: 6.4%.
- Date of event: 31 Dec 2025.
Dellora Investments LP - 31 Dec 2025 SCHEDULE 13G/A Report for TENAX THERAPEUTICS, INC. Common Stock, $0.0001 par value per share (TENX)
- Filing Manager
- Dellora Investments LP
- Reporting Manager
- Dellora Investments LP
- Symbol
- TENX
- Shares outstanding
- 6,266,734 shares
- Disclosed Ownership
- 401,071 shares
- Ownership
- 6.4%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Feb 2026, 09:55:31 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 04 Apr 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Dellora Investments LP disclosed 6.4% ownership in TENAX THERAPEUTICS, INC. Common Stock, $0.0001 par value per share (TENX) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 04 Apr 2025.
- Current filing was accepted on 17 Feb 2026, 09:55.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Dellora Investments Master Fund LP | 5.7% | 355,257 | 0 | 355,257 | /s/ Kevin Pyun | Principal, Dellora Investments Fund GP LLC, its General Partner | |
| Dellora Investments LP | 6.4% | 401,071 | 0 | 401,071 | /s/ Kevin Pyun | Principal, Dellora Investments GP LLC, its General Partner | |
| Kevin Pyun | 6.4% | 401,071 | 0 | 401,071 | /s/ Kevin Pyun | Kevin Pyun |